<?xml version="1.0" encoding="UTF-8"?>
<p>To explore the cellular and molecular determinants of SAMHD1 requirement for kinase inhibitor function, SAMHD1 expression and phosphorylation was measured by Western blot. Both palbociclib and midostaurin blocked SAMHD1 phosphorylation, whereas SAMHD1 protein expression was not affected (
 <xref ref-type="fig" rid="cancers-12-00713-f003">Figure 3</xref>C, 
 <xref ref-type="app" rid="app1-cancers-12-00713">Figure S1B</xref>). In addition, we observed a concomitant dephosphorylation and decreased expression of Rb, a substrate of CDK6, suggesting that palbociclib and midostaurin also affect CDK6-mediated CDK2 phosphorylation of SAMHD1 (
 <xref ref-type="fig" rid="cancers-12-00713-f003">Figure 3</xref>C, 
 <xref ref-type="app" rid="app1-cancers-12-00713">Figure S1B</xref>).
</p>
